(Q41371176)

30 September 2017

1 reference

title

Advances in the therapy for sepsis in children (English)

1 reference

30 September 2017

0 references

Anderson MR

1

1 reference

30 September 2017

Blumer JL

series ordinal

2

1 reference

30 September 2017

publication date

1 February 1997

1 reference

Pediatric Clinics of North America

30 September 2017

published in

1 reference

30 September 2017

volume

44

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

179-205

1 reference

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

The economic impact and cost-effectiveness of monoclonal antibody therapy for sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Effectiveness of adjunctive treatment with steroids in reducing short-term mortality in a high-risk population of children with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Methylene blue increases myocardial function in septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Effect of cortisone on acute streptococcal infections and poststreptococcal complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Steroid controversy in sepsis and septic shock: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

L-arginine pathway in the sepsis syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

The L-arginine-nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

The expanding universe of T-cell subsets: Th1, Th2 and more.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Role of cytokines in determining T-lymphocyte function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Pathogenetic mechanisms of septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Lymphocyte responses and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Effects of a nitric oxide synthase inhibitor in humans with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Serum Cytokine Levels in Human Septic Shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Bacterial meningitis: pathogenesis, pathophysiology, and progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Steroid therapy for bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Plasma nitric oxide levels in newborn infants with sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Correlation of plasma cytokine elevations with mortality rate in children with sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Anti-endotoxin monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

The mortality of hospital-acquired bloodstream infections: need for a new vital statistic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Plasma bactericidal/permeability-increasing protein concentrations in critically ill children with the sepsis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

Dexamethasone treatment for bacterial meningitis in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970469-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70469-7

1 reference

30 September 2017

1 reference